Fromkin Andrew J. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Fromkin Andrew J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $7.44M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-29IMVTImmunovant, Inc.S — Open-market sale210.5K$33.56$7.06M
2026-05-29IMVTImmunovant, Inc.S — Open-market sale11.5K$32.64$375K
2026-05-29IMVTImmunovant, Inc.M — Option exercise16.3K$14.70$239K
2026-05-29IMVTImmunovant, Inc.M — Option exercise77.2K$8.43$651K
2026-05-29IMVTImmunovant, Inc.M — Option exercise71.5K$7.94$568K
2026-05-29IMVTImmunovant, Inc.M — Option exercise31.7K$4.99$158K
2026-04-09IMVTImmunovant, Inc.A — Grant or award13.9K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Fromkin Andrew J.?

Fromkin Andrew J. is a corporate insider — currently tracked as Director of Immunovant, Inc. (IMVT). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Fromkin Andrew J. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Fromkin Andrew J. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($7.44M) across all tracked filings.

Where can I see all of Fromkin Andrew J.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Fromkin Andrew J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.